Abstract:Macrophages are indispensable cellular component in both innate immunity and adaptive immunity. Macrophages show great plasticity and can be specifically shaped by microenvironments in both homeostatic and pathological states. In tumor microenvironments, macrophages are educated to M2-like phenotypes, which are believed to have pro-tumor effects. Applications targeting M2-like tumor-associated macrophages (TAMs) improved outcome in various solid tumors. The significance of macrophages in hematopoietic malignancies was reported and leukemia-associated macrophages (LAMs) have been suggested. However, the phenotypic characteristics of LAMs in different leukemic microenvironments and whether in vivo targeting the LAMs could eliminate their pro-leukemic effects in leukemic microenvironments have not been established. In this study, we analyzed clinical relevance of macrophages in human acute myeloid leukemia (AML), studied phenotypic evolution of bone marrow (BM) and spleen (SP) LAMs in mouse AML and T cell acute lymphoblastic leukemia (T-ALL) models, explored mechanism leading to different LAM phenotypes and tried to eliminate pro-leukemic effects by reprogramming LAMs to have more M1-associated characteristics. The results showed that more CD163 positive M2-like LAMs but not CD68 positive total LAMs correlated with worse prognosis in AML patients. Heterogeneity of LAM activation in tissue-specific leukemic niches was observed in both AML and ALL models, i.e. in SP niche LAMs evolved with more M2 characteristics while in BM niche LAMs evolved with more M1 characteristics. Furthermore, IRF7 contributed to M1 characteristics through the activation of SAPK/JNK pathway. Moreover, targeting IRF7-SAPK/JNK pathway to induce more M1 characteristics in LAMs attenuated their pro-leukemic effects both in vitro and in vivo, and contributed to prolonged survival in leukemia mice. Our study provides the first evidence on how macrophages respond differently to different leukemic niche and the potential target for macrophage based immuno-therapy strategy against leukemia.

Functional Expression of P2X Family Receptors in Macrophages is Affected by Microenvironment in Mouse T Cell Acute Lymphoblastic Leukemia.

[Expression of P2X Family Receptors in Peritoneal Macrophages of Mouse with Acute T Lymphoblastic Leukemia].

P2X7 Promotes the Progression of MLL-AF9 Induced Acute Myeloid Leukemia by Upregulation of Pbx3.

Organ-Specific Microenvironment Modifies Diverse Functional and Phenotypic Characteristics of Leukemia-Associated Macrophages in Mouse T Cell Acute Lymphoblastic Leukemia

Downregulation of Mir-142 Promotes Leukemia Growth in Philadelphia Chromosome-Positive (ph+) Acute Lymphoblastic Leukemia (ALL): A Possible Novel Therapeutic Target?

Effects of Overexpressed P2X7 on Leukemia Progression in Mouse Acute Myeloid Leukemia Model

Hepatic Leukemic Microenvironment Educates Leukemia-Associated Macrophages to a Pro-Inflammatory Phenotype in Notch1-Induced Acute T Cell Leukemia

Leukemia-Associated Macrophages Educated by Organ-Specific Leukemic Microenvironment Acquire Diverse Functions and Gene-Expression Signatures

Function of the P2X7 Receptor in Hematopoiesis and Leukemogenesis

THE PHENOTYPIC CHARACTERISTICS OF LEUKEMIA-ASSOCIATED MACROPHAGES ARE SHAPED BY ORGAN-SPECIFIC LEUKEMIC MICROENVIRONMENTS AND TARGETING IRF7-SAPK/JNK PATHWAY ELIMINATES THEIR PRO-LEUKEMIC EFFECTS

High Level P2X7-Mediated Signaling Impairs Function of Hematopoietic Stem/Progenitor Cells

Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models

P2X1 Enhances Leukemogenesis Through PBX3-BCAT1 Pathways.

Peritoneal Resident Macrophages in Mice with MLL-AF9-induced Acute Myeloid Leukemia Show an M2-like Phenotype.

Macrophages in Leukemia Microenvironment

Characterization of Peritoneal Leukemia-Associated Macrophages in Notch1-induced Mouse T Cell Acute Lymphoblastic Leukemia.

Inherent P2X7 Receptors Regulate Macrophage Functions during Inflammatory Diseases

CSF-1R inhibition disrupts the dialog between leukaemia cells and macrophages and delays leukaemia progression

Hepatic Leukemia-Associated Macrophages Exhibit a Pro-Inflammatory Phenotype in Notch1-induced Acute T Cell Leukemia.

Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche

C1Q Labels a Highly Aggressive Macrophage-Like Leukemia Population Indicating Extramedullary Infiltration and Relapse